Market Overview
Orthopedic ambulatory surgery centers are outpatient healthcare facilities equipped to perform a wide range of musculoskeletal procedures that previously required hospital admission. These centers offer joint replacement surgeries including hip, knee, and shoulder arthroplasty, sports medicine operations, arthroscopic procedures, fracture repair, and spine interventions in a single-day setting.
- •Procedures typically span joint replacement, sports medicine, arthroscopy, and spine surgeries with same-day discharge
- •Operating costs at ASCs are substantially lower than hospital outpatient departments, creating financial incentive for patients and payors alike
- •Regulatory frameworks in the U.S. and Canada have progressively supported expanded scope of practice for ambulatory orthopedic centers
Growth Drivers
The aging North American population is a powerful catalyst, as osteoarthritis and degenerative joint conditions requiring surgical intervention become increasingly prevalent among adults over 50. Simultaneously, orthopedic surgical techniques have advanced considerably, with improved anesthesia protocols, minimally invasive approaches, and enhanced pain management enabling procedures that were once considered too complex for outpatient settings.
- •Rising prevalence of osteoarthritis and musculoskeletal disorders across aging demographics is expanding the addressable patient pool
- •Insurance reimbursement policies have progressively aligned to favor ambulatory surgical centers over traditional hospital settings
- •Cost-conscious healthcare economics are pushing payors, employers, and patients toward lower-cost outpatient alternatives
Segmentation and Regional Analysis
The U.S. dominates the North American orthopedic ASC market due to its larger population base, more extensive ASC regulatory framework, and higher prevalence of employer-sponsored health coverage supporting elective procedures. Within the market, large-joint replacement represents the largest procedure category, followed by sports medicine and upper extremity surgery, with knee procedures commanding the highest volume.
- •The United States accounts for the overwhelming majority of market activity, with Canada representing a smaller but growing segment
- •Large joint replacement procedures, particularly knee and hip arthroplasty, constitute the dominant revenue segment
- •Sun Belt and suburban regions of the U.S. have seen particularly aggressive expansion of orthopedic-focused ASCs driven by favorable demographics
Trends and Outlook
What are the recent trends and outlook?
Robotic-assisted surgery platforms such as Mako, ROSA, and CORI are being increasingly adopted within orthopedic ASCs, enabling greater precision in joint replacement and driving differentiation among competing facilities. Bundled payment models and risk-sharing arrangements between ASCs, implant manufacturers, and payors are expected to deepen, incentivizing efficiency and quality outcomes over volume.
- •Integration of robotic surgical systems is expanding the range of complex procedures that can be safely performed in ambulatory settings
- •Value-based care contracts and bundled payments are reshaping the financial model, rewarding centers that deliver strong clinical outcomes at lower cost
- •Technology advances in patient monitoring and enhanced recovery protocols are expected to further broaden the scope of procedures migrating to ASC environments through the forecast period
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.